Prediabetic StateNCT07298304
Impact of Sorghum Rice on Beta-Cell Function and Insulin Resistance in Prediabetes
A study testing Sorghum Rice and white rice in people with Prediabetic State and Glucose Intolerance, run by Dr. Soetomo General Hospital at 1 site in Indonesia.
Trial summary
Prediabetes is a condition where blood sugar levels are higher than normal but not yet high enough to be diagnosed as diabetes. Without lifestyle changes, people with prediabetes often develop type 2 diabetes, a serious disease affecting millions worldwide. Read more about this study
- Who is it for?
- Ages 18 to 58 years
- Conditions the study is for
- Prediabetic State, Glucose Intolerance, Insulin Resistance
- What is being tested?
- Sorghum Rice and white rice
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 26 participants
- Where
- 1 siteIndonesia
- Study dates
- 1 Mar 2022to 1 Mar 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 58 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Adults aged 18 to 58 years
- Diagnosed with prediabetes which met one of the criteria per PERKENI 2021 as follow:
- Fasting plasma glucose 100-125 mg/dL
- 2-hour postprandial glucose 140-199 mg/dL
- HbA1c 5.7-6.4%
- Willing to comply with dietary monitoring and lifestyle instructions
- Active duty police officers
Who cannot join
- Pregnancy
- History of malignancy
- Diagnosed diabetes mellitus
- Acute infection
- Severe hepatic or renal impairment
- Current use of medication such as: glucose-lowering, corticosteroid, or anti-obesity medications
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Substituting White Rice With Sorghum Rice on Pancreatic Beta-Cell Function and Insulin Resistance in Prediabetes
Prediabetes is a condition where blood sugar levels are higher than normal but not yet high enough to be diagnosed as diabetes. Without lifestyle changes, people with prediabetes often develop type 2 diabetes, a serious disease affecting millions worldwide. Diet plays a crucial role in preventing this progression, and replacing refined grains like white rice with whole grains may help improve metabolic health.
This study investigated whether eating sorghum rice-a nutritious whole grain rich in fiber and natural antioxidants-could affect leptin levels in people with prediabetes. Leptin is a hormone produced by fat cells that helps regulate appetite and energy use. In people with obesity and prediabetes, leptin levels are often abnormally high, which can contribute to insulin resistance and weight gain.
Read more
The investigators studied 26 police officers with prediabetes in Indonesia, randomly dividing them into two groups. One group ate sorghum rice instead of white rice for seven consecutive days, while the other group continued eating white rice. Both groups received standard education about healthy eating and exercise. The investigators measured their leptin levels before and after the week-long intervention.
Our hypothesis was that replacing white rice with sorghum rice would significantly lower leptin levels.
Read the detailed description
This open-label randomized pre-post experimental study was designed to evaluate the metabolic effects of short-term sorghum rice consumption on serum leptin levels in prediabetic individuals. The study was conducted over a two-month period (March to April 2022) at the Bojonegoro Police Polyclinic and Bojonegoro Bhayangkara Hospital in East Java, Indonesia.
Rationale and Background The study addresses a critical gap in understanding dietary interventions for prediabetes management in Indonesia, where white rice consumption is a dominant dietary pattern associated with increased type 2 diabetes risk. Sorghum (Sorghum bicolor L.) represents a promising functional whole grain alternative, containing high levels of dietary fiber, resistant starch, and phenolic compounds with antioxidant properties. These bioactive components may influence adipokine profiles, particularly leptin, an adipocyte-derived hormone that plays a central role in energy homeostasis and is frequently dysregulated in prediabetic states. The study specifically targeted police officers, a population with unique physical activity patterns and occupational stress factors that may influence metabolic responses.
Twenty-six prediabetic participants were recruited through simple random sampling and randomly assigned in a 1:1 ratio to either the intervention (sorghum rice) group or the control (white rice) group, with 13 participants in each arm. The sample size was calculated using a standard formula for comparing numerical data between two independent groups, accounting for expected differences in leptin levels based on preliminary data and published literature. Randomization was performed to minimize selection bias and ensure comparable baseline characteristics between groups.
Participants in the intervention group completely substituted their regular white rice intake with sorghum rice for seven consecutive days. The sorghum rice was prepared according to standardized cooking procedures supervised by a registered dietitian to ensure consistency in preparation methods and palatability. The daily amount of sorghum or white rice consumed was individually calculated based on each participant's total daily energy requirements, determined using standard anthropometric measurements and physical activity assessments. This personalized approach ensured that participants maintained their usual caloric intake while only varying the grain type consumed.
The control group continued their habitual white rice consumption throughout the study period. Both groups received identical standardized lifestyle education sessions focusing on balanced nutrition principles and the importance of regular physical activity in prediabetes management, ensuring that any observed differences could be attributed to the grain substitution rather than differential educational interventions.
To ensure adherence to the assigned dietary intervention, participants were required to photograph each meal containing the assigned grain type and submit these images daily via mobile messaging applications. A dedicated research dietitian reviewed all submitted photographs within 24 hours to verify compliance and provide immediate feedback or guidance when needed. Participants were instructed to maintain all other aspects of their usual dietary habits, including portion sizes of non-grain foods, meal timing, and beverage consumption. This monitoring system allowed for real-time assessment of intervention fidelity while minimizing participant burden.
Anthropometric Assessments Height was measured to the nearest 0.1 centimeter using a calibrated wall-mounted stadiometer with participants standing barefoot in an erect position. Body weight was measured to the nearest 0.1 kilogram using a calibrated digital scale with participants wearing light clothing and no shoes. Body Mass Index (BMI) was calculated using the standard formula: weight in kilograms divided by height in meters squared (kg/m²). All anthropometric measurements were performed by trained research staff using standardized techniques at both baseline and follow-up assessments to ensure measurement consistency.
Biochemical Analysis Venous blood samples were collected from all participants after an overnight fast (minimum 8 hours) at baseline (day 0) and immediately following the completion of the seven-day intervention (day 7). Samples were collected in the morning (between 7:00-9:00 AM) to minimize circadian variation in hormone levels. Blood samples were allowed to clot at room temperature for 30 minutes, then centrifuged at 3,000 rpm for 10 minutes. Serum was separated and stored at -80°C until batch analysis to reduce inter-assay variability.
Serum leptin concentrations were quantified using a commercially available enzyme-linked immunosorbent assay (ELISA) kit (CAN-L-4260, Diagnostic Biochem Canada Inc., Canada) following the manufacturer's protocol. All samples were analyzed in duplicate, and the mean value was used for statistical analysis. The assay has a sensitivity of 0.5 ng/mL and demonstrates minimal cross-reactivity with other adipokines. Quality control samples were included in each assay run to ensure accuracy and precision. The change in leptin levels (delta leptin or Δ leptin) was calculated by subtracting the pre-intervention value from the post-intervention value for each participant.
Data analysis followed a pre-specified statistical plan. Continuous variables were assessed for normality using the Shapiro-Wilk test before selecting appropriate parametric or non-parametric tests. Between-group comparisons at baseline were performed to ensure group comparability. Within-group changes from baseline to post-intervention were analyzed using paired tests, while between-group differences in change scores were evaluated using independent samples tests. Subgroup analyses were conducted to explore potential effect modification by obesity status (BMI <30 vs ≥30 kg/m²). Correlation analyses examined the relationship between age and leptin change within each treatment group to identify potential demographic factors influencing treatment response. All statistical tests were two-tailed with a significance level set at α=0.05.
All study procedures were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and Good Clinical Practice guidelines. The study protocol received approval from the Health Research Ethics Committee of Health Research Ethics Committee Universitas Airlangga School of Medicine, Surabaya, Indonesia (approval number 52/EC/KEPK/FKUA/2022) prior to participant enrollment. All participants provided written informed consent after receiving detailed oral and written explanations of the study procedures, potential risks, and benefits. Participants were free to withdraw from the study at any time without penalty. Adverse events related to the dietary intervention were monitored throughout the study period through participant self-report and direct inquiry during follow-up visits.
- Being tested
- Sorghum Rice, white rice
- Keywords
- Leptin, obesity, prediabetic, sorghum
- Medical subject headings
- Prediabetic State, Glucose Intolerance, Insulin Resistance, Obesity, Overweight
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sorghum RiceDietary supplement
Participants completely substituted all white rice intake with sorghum rice (Sorghum bicolor L.) for seven consecutive days. The amount consumed at each meal was individually calculated based on participant's daily caloric requirements. Sorghum rice was prepared using standardized cooking procedures supervised by a registered dietitian. Participants consumed sorghum rice with regular meals according to usual eating patterns. Dietary compliance was monitored daily through meal photography reviewed by research staff. Participants maintained all other usual dietary habits including portion sizes of non-grain foods, meal timing, and beverages. Both groups received identical standard lifestyle education on balanced nutrition and physical activity for prediabetes management.
white riceDietary supplement
Participants continued habitual white rice (Oryza sativa L.) consumption for seven consecutive days without modification. The amount consumed at each meal was individually calculated based on participant's daily caloric requirements to ensure comparability with the intervention group. Participants consumed white rice with regular meals according to usual eating patterns. Dietary compliance was monitored daily through meal photography reviewed by research staff. Participants maintained all other usual dietary habits including portion sizes of non-grain foods, meal timing, and beverages. Control participants received identical standard lifestyle education on balanced nutrition and physical activity for prediabetes management.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Arm (Sorghum Group) | Experimental | 13 participants Consumed sorghum rice as a dietary substitute for 7 consecutive days Received standard lifestyle education Receives: Dietary Supplement: Sorghum Rice |
| Control Arm (White Rice Group): | Active comparator | 13 participants Continued regular white rice consumption Received standard lifestyle education Receives: Dietary Supplement: white rice |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Serum Leptin
Change in serum leptin concentration from baseline to day 7, measured using enzyme-linked immunosorbent assay (ELISA). Delta leptin (Δ leptin) calculated as the difference between post-intervention and pre-intervention leptin levels.
Time Frame: Baseline (Day 0) and Day 7 (after 7-day intervention)Unit of Measure: Nanograms per milliliter (ng/mL)
Measured: From Baseline to day 7
Secondary outcomes (1)
Serum Leptin Levels at Baseline
Baseline serum leptin concentration measured using enzyme-linked immunosorbent assay (ELISA) to establish pre-intervention values and assess differences between groupsTime Frame: Baseline (Day 0)Unit of Measure: Nanograms per milliliter (ng/mL)
Measured: day 0, before intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Dec 2025
- Study start1 Mar 2022
- Primary completion1 Apr 2022
- Study completion1 Mar 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Prediabetic StateStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 26 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dr. Soetomo General Hospital
- Sponsor type
- Other government
- Collaborators
- Universitas Airlangga
- Responsible party
- Principal investigator, Dr. Sony Wibisono M dr., SpPD., KEMD, Dr. Soetomo General Hospital
- Investigators
- Sony Wibisono Mudjanarko, dr., Sp.PD, K-EMD, PhD, Principal investigator, Dr. Soetomo General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07298304
- Sponsor's protocol ID
- 52/EC/KEPK/FKUA/2022
- Status last verified
- Dec 2025
- First submitted
- 25 Nov 2025
- Last updated
- 24 Dec 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Substituting White Rice With Sorghum Rice on Pancreatic Beta-Cell Function and Insulin Resistance in Prediabetes
- ClinicalTrials.gov ID
- NCT07298304
- Acronym / sponsor ID
- 52/EC/KEPK/FKUA/2022
- Keywords
- Leptin, obesity, prediabetic, sorghum
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 26 participants (actual)
- Lead sponsor
- Dr. Soetomo General HospitalOther government
- Collaborators
- Universitas Airlangga
- Study start
- 1 Mar 2022 (actual)
- Primary completion
- 1 Apr 2022 (actual)
- Study completion
- 1 Mar 2023 (actual)
- First posted
- 23 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prediabetes is a condition where blood sugar levels are higher than normal but not yet high enough to be diagnosed as diabetes. Without lifestyle changes, people with prediabetes often develop type 2 diabetes, a serious disease affecting millions worldwide. Diet plays a crucial role in preventing this progression, and replacing refined grains like white rice with whole grains may help improve metabolic health.
This study investigated whether eating sorghum rice-a nutritious whole grain rich in fiber and natural antioxidants-could affect leptin levels in people with prediabetes. Leptin is a hormone produced by fat cells that helps regulate appetite and energy use. In people with obesity and prediabetes, leptin levels are often abnormally high, which can contribute to insulin resistance and weight gain.
The investigators studied 26 police officers with prediabetes in Indonesia, randomly dividing them into two groups. One group ate sorghum rice instead of white rice for seven consecutive days, while the other group continued eating white rice. Both groups received standard education about healthy eating and exercise. The investigators measured their leptin levels before and after the week-long intervention.
Our hypothesis was that replacing white rice with sorghum rice would significantly lower leptin levels.
Detailed description
This open-label randomized pre-post experimental study was designed to evaluate the metabolic effects of short-term sorghum rice consumption on serum leptin levels in prediabetic individuals. The study was conducted over a two-month period (March to April 2022) at the Bojonegoro Police Polyclinic and Bojonegoro Bhayangkara Hospital in East Java, Indonesia.
Rationale and Background The study addresses a critical gap in understanding dietary interventions for prediabetes management in Indonesia, where white rice consumption is a dominant dietary pattern associated with increased type 2 diabetes risk. Sorghum (Sorghum bicolor L.) represents a promising functional whole grain alternative, containing high levels of dietary fiber, resistant starch, and phenolic compounds with antioxidant properties. These bioactive components may influence adipokine profiles, particularly leptin, an adipocyte-derived hormone that plays a central role in energy homeostasis and is frequently dysregulated in prediabetic states. The study specifically targeted police officers, a population with unique physical activity patterns and occupational stress factors that may influence metabolic responses.
Twenty-six prediabetic participants were recruited through simple random sampling and randomly assigned in a 1:1 ratio to either the intervention (sorghum rice) group or the control (white rice) group, with 13 participants in each arm. The sample size was calculated using a standard formula for comparing numerical data between two independent groups, accounting for expected differences in leptin levels based on preliminary data and published literature. Randomization was performed to minimize selection bias and ensure comparable baseline characteristics between groups.
Participants in the intervention group completely substituted their regular white rice intake with sorghum rice for seven consecutive days. The sorghum rice was prepared according to standardized cooking procedures supervised by a registered dietitian to ensure consistency in preparation methods and palatability. The daily amount of sorghum or white rice consumed was individually calculated based on each participant's total daily energy requirements, determined using standard anthropometric measurements and physical activity assessments. This personalized approach ensured that participants maintained their usual caloric intake while only varying the grain type consumed.
The control group continued their habitual white rice consumption throughout the study period. Both groups received identical standardized lifestyle education sessions focusing on balanced nutrition principles and the importance of regular physical activity in prediabetes management, ensuring that any observed differences could be attributed to the grain substitution rather than differential educational interventions.
To ensure adherence to the assigned dietary intervention, participants were required to photograph each meal containing the assigned grain type and submit these images daily via mobile messaging applications. A dedicated research dietitian reviewed all submitted photographs within 24 hours to verify compliance and provide immediate feedback or guidance when needed. Participants were instructed to maintain all other aspects of their usual dietary habits, including portion sizes of non-grain foods, meal timing, and beverage consumption. This monitoring system allowed for real-time assessment of intervention fidelity while minimizing participant burden.
Anthropometric Assessments Height was measured to the nearest 0.1 centimeter using a calibrated wall-mounted stadiometer with participants standing barefoot in an erect position. Body weight was measured to the nearest 0.1 kilogram using a calibrated digital scale with participants wearing light clothing and no shoes. Body Mass Index (BMI) was calculated using the standard formula: weight in kilograms divided by height in meters squared (kg/m²). All anthropometric measurements were performed by trained research staff using standardized techniques at both baseline and follow-up assessments to ensure measurement consistency.
Biochemical Analysis Venous blood samples were collected from all participants after an overnight fast (minimum 8 hours) at baseline (day 0) and immediately following the completion of the seven-day intervention (day 7). Samples were collected in the morning (between 7:00-9:00 AM) to minimize circadian variation in hormone levels. Blood samples were allowed to clot at room temperature for 30 minutes, then centrifuged at 3,000 rpm for 10 minutes. Serum was separated and stored at -80°C until batch analysis to reduce inter-assay variability.
Serum leptin concentrations were quantified using a commercially available enzyme-linked immunosorbent assay (ELISA) kit (CAN-L-4260, Diagnostic Biochem Canada Inc., Canada) following the manufacturer's protocol. All samples were analyzed in duplicate, and the mean value was used for statistical analysis. The assay has a sensitivity of 0.5 ng/mL and demonstrates minimal cross-reactivity with other adipokines. Quality control samples were included in each assay run to ensure accuracy and precision. The change in leptin levels (delta leptin or Δ leptin) was calculated by subtracting the pre-intervention value from the post-intervention value for each participant.
Data analysis followed a pre-specified statistical plan. Continuous variables were assessed for normality using the Shapiro-Wilk test before selecting appropriate parametric or non-parametric tests. Between-group comparisons at baseline were performed to ensure group comparability. Within-group changes from baseline to post-intervention were analyzed using paired tests, while between-group differences in change scores were evaluated using independent samples tests. Subgroup analyses were conducted to explore potential effect modification by obesity status (BMI <30 vs ≥30 kg/m²). Correlation analyses examined the relationship between age and leptin change within each treatment group to identify potential demographic factors influencing treatment response. All statistical tests were two-tailed with a significance level set at α=0.05.
All study procedures were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and Good Clinical Practice guidelines. The study protocol received approval from the Health Research Ethics Committee of Health Research Ethics Committee Universitas Airlangga School of Medicine, Surabaya, Indonesia (approval number 52/EC/KEPK/FKUA/2022) prior to participant enrollment. All participants provided written informed consent after receiving detailed oral and written explanations of the study procedures, potential risks, and benefits. Participants were free to withdraw from the study at any time without penalty. Adverse events related to the dietary intervention were monitored throughout the study period through participant self-report and direct inquiry during follow-up visits.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention Arm (Sorghum Group) | Experimental | Dietary Supplement: Sorghum Rice13 participants Consumed sorghum rice as a dietary substitute for 7 consecutive days Received standard lifestyle education |
| Control Arm (White Rice Group): | Active comparator | Dietary Supplement: white rice13 participants Continued regular white rice consumption Received standard lifestyle education |
Who may qualify
- Ages
- 18 to 58 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Adults aged 18 to 58 years
- Diagnosed with prediabetes which met one of the criteria per PERKENI 2021 as follow:
- Fasting plasma glucose 100-125 mg/dL
- 2-hour postprandial glucose 140-199 mg/dL
- HbA1c 5.7-6.4%
Key exclusion criteria (6 listed)
- Pregnancy
- History of malignancy
- Diagnosed diabetes mellitus
- Acute infection
- Severe hepatic or renal impairment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sorghum RiceParticipants completely substituted all white rice intake with sorghum rice (Sorghum bicolor L.) for seven consecutive days. The amount consumed at each meal was individually calculated based on participant's daily caloric requirements. Sorghum rice was prepared using standardized cooking procedures supervised by a registered dietitian. Participants consumed sorghum rice with regular meals according to usual eating patterns. Dietary compliance was monitored daily through meal photography reviewed by research staff. Participants maintained all other usual dietary habits including portion sizes of non-grain foods, meal timing, and beverages. Both groups received identical standard lifestyle education on balanced nutrition and physical activity for prediabetes management. | Dietary supplement | Intervention Arm (Sorghum Group) |
| white riceParticipants continued habitual white rice (Oryza sativa L.) consumption for seven consecutive days without modification. The amount consumed at each meal was individually calculated based on participant's daily caloric requirements to ensure comparability with the intervention group. Participants consumed white rice with regular meals according to usual eating patterns. Dietary compliance was monitored daily through meal photography reviewed by research staff. Participants maintained all other usual dietary habits including portion sizes of non-grain foods, meal timing, and beverages. Control participants received identical standard lifestyle education on balanced nutrition and physical activity for prediabetes management. | Dietary supplement | Control Arm (White Rice Group): |
Primary outcome
Change in Serum Leptin
Time frame: From Baseline to day 7
Change in serum leptin concentration from baseline to day 7, measured using enzyme-linked immunosorbent assay (ELISA). Delta leptin (Δ leptin) calculated as the difference between post-intervention and pre-intervention leptin levels. Time Frame: Baseline (Day 0) and Day 7 (after 7-day intervention)Unit of Measure: Nanograms per milliliter (ng/mL)
1 secondary outcome
Serum Leptin Levels at Baseline
Time frame: day 0, before intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Dec 2025.
- Individual participant dataSharing planned: No
Related trials for Prediabetic State
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
RecruitingObservational study
Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data Analysis for Precision Nutrition.
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Artificial Intelligence Mobile Application
RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Overweight, Prediabetic State
Enrolling by invitationEarly Phase 1
Truway Diagnostic Tools in Primary Care
Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Recruiting
CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
PreDiabetes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sony Wibisono Mudjanarko, dr., Sp.PD, K-EMD, PhD principal investigator
Dr. Soetomo General Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Sorghum Rice and white rice in people with Prediabetic State and Glucose Intolerance, run by Dr. Soetomo General Hospital at 1 site in Indonesia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Serum Leptin (time frame: From Baseline to day 7). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.